Global Cord Blood Corporation
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
On April 29, 2022, Global Cord announced a deal to acquire Cellenkos Inc. for over $1 billion, paid through cash and shares, leading to significant shareholder dilution. Following the announcement, the company’s stock price dropped by 28.6%. Subsequently, on May 3, Blue Ocean filed a petition against the acquisition, criticizing its value and the approval process, resulting in another stock price drop of 9.1%. Further complications arose when the Grand Court of the Cayman Islands intervened in September 2022, suspending the directors of Global Cord due to alleged financial mismanagement related to the transaction. This led to a halt in trading of Global Cord’s shares and eventually, in June 2023, the company was delisted from the NYSE by the SEC.
